Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis
Clinical trial NCT01320579 · COMPLETED
Trial details
- NCT number
- NCT01320579
- Sponsor
- BioCis Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-06-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.